WiSP

Company Overview

Snapshot

Founded in December 2022 by Liat Kaplan, Aviv Kaplan, and David Avraham, WiSP operates with 11–50 employees. The company is currently in the Pre-Funding stage, developing a solution for drink spiking detection.

Business overview

WiSP is a Health Tech & Life Sciences company focused on developing a drink spiking detector. The company leverages Raman spectroscopy, a non-destructive analytical technique, to identify the molecular composition of substances. By utilizing laser light, WiSP produces a unique spectral fingerprint for each material, enabling precise identification of drugs. The system integrates artificial intelligence to analyze collected data, continuously enhancing its algorithms for improved accuracy and speed. WiSP's technology aims to provide instant and accurate results without altering the sample, serving markets focused on safety and security.

Company Intelligence Q&A

What technology does WiSP utilize for drug detection?

WiSP utilizes Raman spectroscopy, a non-destructive analytical technique, to identify the molecular composition of substances by producing a unique spectral fingerprint for each material.

How does WiSP enhance its detection capabilities?

WiSP employs artificial intelligence to analyze data collected by its system, continuously enhancing algorithms for improved accuracy and speed in drug detection.

When was WiSP founded?

WiSP was founded in December 2022.

Who are the co-founders of WiSP?

The co-founders of WiSP are Liat Kaplan, Aviv Kaplan, and David Avraham.

What is WiSP's current product stage?

WiSP's product is currently in the Beta stage, as of May 2025.